Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Ekberg H |
Calcineurin inhibitor sparing in renal transplantation. |
2008 |
Transplantation |
pmid:18813097
|
Fischer L et al. |
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. |
2015 |
Transplantation |
pmid:26151607
|
Satterthwaite R et al. |
Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. |
1998 |
Transplantation |
pmid:9484771
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Ouyang J et al. |
Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. |
2005 |
Transplantation |
pmid:15912108
|
Boyer O et al. |
Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil. |
2005 |
Transplantation |
pmid:15912111
|
Abbott KC et al. |
New-onset gout after kidney transplantation: incidence, risk factors and implications. |
2005 |
Transplantation |
pmid:16340779
|
Villanueva G and Baldwin D |
Rosiglitazone therapy of posttransplant diabetes mellitus. |
2005 |
Transplantation |
pmid:16340782
|
Numakura K et al. |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. |
2005 |
Transplantation |
pmid:16340785
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Shihab FS et al. |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. |
2009 |
Transplantation |
pmid:19202436
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Pirsch JD et al. |
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. |
1997 |
Transplantation |
pmid:9112351
|
Jindal RM et al. |
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7519799
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Bellon H et al. |
The Effect of Immunosuppression on Airway Integrity. |
2017 |
Transplantation |
pmid:28471870
|
Barten MJ et al. |
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. |
2004 |
Transplantation |
pmid:15114077
|
Kiuchi T |
CNIs: immediate benefits but storing problems for the future? |
2008 |
Transplantation |
pmid:18946338
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Abadja F et al. |
Impact of mycophenolic acid and tacrolimus on Th17-related immune response. |
2011 |
Transplantation |
pmid:21818055
|
Shimada T et al. |
Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. |
2002 |
Transplantation |
pmid:12451243
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Nakata Y et al. |
Tacrolimus and myocardial hypertrophy. |
2000 |
Transplantation |
pmid:10830241
|
Hanto DW and Chudzinski R |
What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? |
2009 |
Transplantation |
pmid:19155968
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Langrehr JM et al. |
Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. |
1992 |
Transplantation |
pmid:1384185
|
Pape E et al. |
Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations. |
2015 |
Transplantation |
pmid:26308424
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Wang K et al. |
Transplantation of infantile bladder in rats: an alternative procedure for bladder augmentation. |
2001 |
Transplantation |
pmid:11213059
|
Nakajima K et al. |
Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506. |
1988 |
Transplantation |
pmid:2454521
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Pascual J et al. |
Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. |
2010 |
Transplantation |
pmid:20335831
|
Sahara H et al. |
Beneficial effects of perioperative low-dose inhaled carbon monoxide on pulmonary allograft survival in MHC-inbred CLAWN miniature swine. |
2010 |
Transplantation |
pmid:21076382
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Chan L et al. |
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. |
2008 |
Transplantation |
pmid:18360262
|
Murase N et al. |
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. |
1993 |
Transplantation |
pmid:7678353
|
Herold KC et al. |
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. |
1993 |
Transplantation |
pmid:7678356
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Peduto G et al. |
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. |
2000 |
Transplantation |
pmid:10919579
|
Gruber SA and Doshi MD |
Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. |
2010 |
Transplantation |
pmid:20440195
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|
Wong W et al. |
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors? |
2005 |
Transplantation |
pmid:16082321
|
Mendez R et al. |
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. |
2005 |
Transplantation |
pmid:16082323
|
Oku M et al. |
Hepatocyte growth factor sustains T regulatory cells and prolongs the survival of kidney allografts in major histocompatibility complex-inbred CLAWN-miniature swine. |
2012 |
Transplantation |
pmid:22158517
|